Stocks and Investing Stocks and Investing
Fri, April 6, 2018
Thu, April 5, 2018

Geoff Meacham Downgraded (BIIB) to Hold on, Apr 5th, 2018


Published on 2024-10-26 04:16:58 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of Barclays, Downgraded "Biogen Inc." (BIIB) to Hold on, Apr 5th, 2018.

Geoff has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, 1 agrees with Geoff's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $350 on, Wednesday, January 24th, 2018


These are the ratings of the 5 analyists that currently disagree with Geoff


  • Ian Somaiya of "BMO Capital" Maintained at Buy with Decreased Target to $393 on, Monday, March 5th, 2018
  • Salim Syed of "Mizuho" Maintained at Strong Buy with Increased Target to $433 on, Monday, February 5th, 2018
  • Carter Gould of "UBS" Upgraded from Hold to Strong Buy on, Wednesday, January 31st, 2018
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $363 on, Friday, January 26th, 2018
  • Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $400 on, Friday, January 26th, 2018
Contributing Sources